Business
Recreational vs. Medical Marijuana Labeling – Enjoying the Cannabis High While Healing with Medicine?
Should you be able to enjoy being high while using your healing medical marijuana?
The Case for Euphoria as an Added Benefit in the Healing Process
Reddit link on the debate is here.
When you feel ill, unwell, unhealthy, bad…a physician will prescribe you some medicine and would urge you to rest. In most cases, the pharmaceuticals will reduce the symptoms and potentially make you drowsy (and some other side effects too) and if all goes well…you’ll get better.
Irrespective of the pharma med they give you (except for opioids), these drugs don’t really provide any other element other than reducing the prevalence of symptoms. Which is why when it comes to cannabis as a medicine – many people claim it isn’t due to the fact that you ALSO feel good when you consume it.
In other words – one of the side effects of marijuana is euphoria.
The reason why I’m chewing on this concept today is because of a post I saw on Reddit that said the following;
the fact that the two types of acceptable marijuana usage (from the US) are differentiated with the names ‘recreational’ and ‘medicinal’ implies that recreation is not healing while also implying that medicine is meant to be neither fun nor freeing. – Some Reddit User
This is what prompted me to explore this question some more. There are of course a few drugs that do make you feel “high” such as Pseudoephedrine, Dextromethorphan, some cold medicines, etc. This is where the term, “Robo-Tripping” comes from – from teenagers abusing cold medicine to get a “high”.
However, all of these medicines really don’t make you feel euphoric. You would feel “drugged”, you would feel “stoned”, but euphoric is hardly the word you’d use to describe these feelings. Furthermore, in order to get these effects, you have to abuse the medicine.
This is where cannabis differs greatly.
With cannabis, a single puff of a joint could be more than enough to awaken the mind to new sensations, deep relaxation, and of course – a brighter tint to reality.
Getting Healthier Isn’t Supposed to Feel Good
The main logic behind separating euphoria and medicine is that some people argue that if medicine made you feel “euphoric”, people would abuse it to get high. However, this premise falls flat on its face when we see kids abusing diabetes medicine to feel “bloaty”. There is no inherent “euphoric feeling” when it comes to diabetes medication – yet, some people still try to get high off it.
This means that “euphoria” isn’t the driving factor for abuse. Perhaps, the people taking the drugs are looking for euphoria and are willing to take pharmaceuticals in great quantities to achieve the euphoria.
The question being, “Does this make things safer for people or riskier?” In the case of cannabis, euphoria is one of the main side effects, meaning you don’t need a lot to feel “high”, which means that the potential for excessive abuse is also greatly diminished.
This isn’t to say that there won’t be some depressed teen bong-ripping their problems away – it simply means that in terms of lethality, the cannabis is a far less damaging substance than let’s say drinking 6-“5 Hour Energy” drinks in less than an hour to feel like you’re coked out.
Even the Bong-ripping teen will be at a lower risk of incurring a lethal dose, than someone who abuses energy drinks daily. I’m also certain that health wise, the cannabis user would be “healthier”. And this is only taking into consideration a heavy cannabis user who bong rips budder every morning to open his or her eyelids.
If the drugs that they sell us do not have the intended consequence of euphoria, yet some people still abuse it to get high which makes it infinitely more risky to the user – perhaps euphoria in itself isn’t the problem. Perhaps, the type of person engaging in this type of risky behavior will try to get high irrespective of the substance.
Yet statistically, the vast majority of the people consuming those drugs DO NOT use it to get high. They use it to treat their conditions and according to their doctor’s recommendations. It’s only in the case of opioids that the “abuse problem” becomes a problem.
For the other drugs like Nyquil, Cough syrups and the likes, the abuse is minimal and while in an ideal world we’d have people not engaging in risky behavior – we don’t live in an ideal world…we’re here now with all the crazy pill snarfing teens out there…and this is a reality we must accept.
The good news is – it’s a fairly small portion of teens that do this. More teens abuse alcohol than other drugs because alcohol is socially accepted. Getting “high” is socially frowned upon…unless your version of “high” is “drunk – then by all means!
But there is another element to Euphoria that we must also consider. Perhaps the reason these people seek out the euphoria is because they are trying to heal wounds that the eye cannot see.
The Case for Euphoria in (certain) Medicine
When you’re feeling “unwell” you’re also “feeling like shit”. In that, most people suffer emotionally from their affliction on top of the physical discomfort they feel from the actual disease. Everyone who has had a “severe cold” or some other physical ailment can attest that the “pain” captures the awareness.
If you are in pain, you’re constantly focusing in on the sensations in the body – which in turn brings the pain back into your awareness and in turn increases the sensations in the body. This dance of the mind and the body keeps the person locked in the moment of suffering.
When you take medicine that only treats the physical ailments – you may experience “some” alleviation, however, most people don’t “feel” hopeful about life. They don’t have any aspirations or excitement beyond “not feeling pain anymore”.
With cannabis, this is not the case. With cannabis, you get both the diminishing of the physical symptom, but also a boost in the mental appreciation of your situation. Euphoria lifts the soul out of a pit of depression (often associated with chronic illness), which in turn helps the body heal quicker.
There are plenty of studies that indicate that simply having a positive outlook can significantly impact the healing process in a positive way. When you’re stuck in a pity party because of your illness, a bit of euphoria might be all you need to kick your mind back into a more resourceful state.
I don’t understand why “feeling good” should be excluded from medicine, when it has a medical benefit by itself. I do understand the fear of abuse, however – as we have established before that those who will abuse will do so whether a medicine is euphoric by nature or not.
Furthermore, drug abuse is an issue of drug education – if we teach people to consume drugs responsibly, we would not eliminate drug abuse, but greatly diminish it.
Final Thoughts
Feeling Good while Getting Better should not necessarily be separate when it comes to healing. In certain conditions, things like Cancer, Chronic Pain, etc…a positive outlook on life can make all the difference.
Additionally, understanding that most people won’t abuse drugs we should not limit a substance because “some” can abuse it. Under that logic, we should ban all cars because “some people” are going to get drunk and drive.
Yet we don’t ban alcohol or driving…
I would like to start seeing studies on the “positive effects of euphoria in the process of healing”, which has not been studied at all. Ever! At the very least, nothing concrete that I discovered during my research.
Perhaps we should first understand these things before we simply declare them wrong.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
AI & Technology
Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations
Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).
The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.
Trial Push Despite Multi-Million Euro Settlement
The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.
Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.
A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.
Allegations of VAT Evasion Through Marketplace Sellers
At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.
Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.
Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.
Italian Government Named as Affected Party
In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.
Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.
Multiple Investigations Add to Pressure
The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.
Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.
In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.
Amazon Denies Allegations
Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.
Broader Impact on Europe’s Digital Economy
If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.
With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
